Higher plasma ApoJ levels are reported to be associated with atrophy of the entorhinal cortex and faster cognitive decline in AD [20], as well as involved in clearance of amyloid beta (Aβ) [41]. This evidence concerns the gene CLU and Alzheimer disease.